Warning: The NCBI web site requires JavaScript to function. more...
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States-Mexico border.
Baumbach JP, Foster LN, Mueller M, Cruz MF, Arbona S, Melville S, Ramos R, Strathdee SA.
Harm Reduct J. 2008 Nov 16;5:33.
Related citations
Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence.
Frost SD, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, Magis-Rodriguez C, Strathdee SA.
J Urban Health. 2006 Nov;83(6 Suppl):i83-97.
Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.
Moyer LB, Brouwer KC, Brodine SK, Ramos R, Lozada R, Cruz MF, Magis-Rodriguez C, Strathdee SA.
Drug Alcohol Rev. 2008 Jan;27(1):39-45.
Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8.
Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA.
Samuel MC, Doherty PM, Bulterys M, Jenison SA.
Epidemiol Infect. 2001 Dec;127(3):475-84.
The role of needle exchange programs in HIV prevention.
Vlahov D, Junge B.
Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.
Cross-border drug injection relationships among injection drug users in Tijuana, Mexico.
Wagner KD, Pollini RA, Patterson TL, Lozada R, Ojeda VD, Brouwer KC, Vera A, Volkmann TA, Strathdee SA.
Drug Alcohol Depend. 2011 Jan 15;113(2-3):236-41.
Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
Eur J Epidemiol. 1998 Sep;14(6):555-61.
Aryl hydrocarbon receptor-mediated activity of particulate organic matter from the Paso del Norte airshed along the U.S.-Mexico border.
Arrieta DE, Ontiveros CC, Li WW, Garcia JH, Denison MS, McDonald JD, Burchiel SW, Washburn BS.
Environ Health Perspect. 2003 Aug;111(10):1299-305.
Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH; DUIT Study Team.
Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S4-17. Epub 2007 Jun 19.
HIV sexual risk behaviors among injection drug users in Shanghai.
Zhao M, Du J, Lu GH, Wang QY, Xu H, Zhu M, McCoy CB.
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S43-7.
Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF.
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S18-24.
Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
AIDS. 1996 Mar;10(3):311-7.
Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
De P, Cox J, Boivin JF, Platt RW, Jolly AM.
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):355-61.
Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, Asare I, Hesse IF, Mensah G.
BMC Infect Dis. 2008 Mar 7;8:33.
Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
De P, Jolly A, Cox J, Boivin JF.
Can J Public Health. 2006 May-Jun;97(3):207-9.
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS.
Prev Med. 2009 Aug;49(1):68-73. Epub 2009 May 4.
Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users.
Lee HC, Ko NY, Lee NY, Chang CM, Ko WC.
J Formos Med Assoc. 2008 May;107(5):404-11.
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China.
Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF.
Int J Epidemiol. 2004 Feb;33(1):182-8.
Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, Des Jarlais DC.
Int J STD AIDS. 2006 Sep;17(9):621-6.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on